Ovarian cancer: making sense of the diagnosis and the road ahead.
Ovarian, fallopian tube and primary peritoneal cancers are closely related and treated the same way. Surgery and chemotherapy remain central, and genetic results now open up maintenance treatments that keep the disease away for longer.
READING YOUR REPORT
Three results that shape the plan
What kind of ovarian cancer is it?
"Ovarian cancer" covers several diseases that look and behave differently. The cell type guides both surgery and medicines.
| TYPE | WHAT IT MEANS | TREATMENTS USUALLY DISCUSSED |
|---|---|---|
| High-grade serous | The most common type; often begins in the fallopian tube and is found at a later stage. | Surgery and platinum chemotherapy, then maintenance with PARP inhibitors and/or bevacizumab |
| Clear cell & endometrioid | Sometimes linked to endometriosis; clear cell is seen more often in Asian women. | Surgery is key; chemotherapy depends on stage |
| Low-grade serous & mucinous | Slower-growing and less sensitive to standard chemotherapy. | Surgery; hormone therapy is an option for some low-grade serous cancers |
| Germ cell & stromal | Rare; germ cell tumours mostly affect younger women. | Fertility-sparing surgery is often possible; germ cell tumours respond very well to chemotherapy |
OTHER WORDS YOU MAY SEE
CA-125
A blood marker used to track response and follow-up.
Debulking
Surgery aiming to remove all visible cancer in the abdomen.
Platinum-sensitive
The cancer responded well to platinum chemotherapy; guides later choices.
Primary peritoneal
Starts in the abdominal lining; treated like ovarian cancer.
How far has it spread?
Staging (the FIGO system) is usually confirmed during surgery, when the surgeon can see and sample the abdomen.
I
In one or both ovaries or tubes.
II
Spread to other organs within the pelvis.
III
The abdominal lining or lymph nodes. The most common stage at diagnosis.
IV
Beyond the abdomen, or inside organs such as the liver.
The standard treatment pathway
Most women have surgery and chemotherapy, in either order. Maintenance treatment afterwards aims to delay the cancer's return.
TREATS THE AREA
Local treatment
Surgery — staging and removal of as much cancer as possible, ideally by a gynaecological oncologist.
Radiotherapy — used only occasionally, for example to ease symptoms from a single area.
TREATS THE WHOLE BODY
Systemic treatment
Chemotherapy — usually platinum-based; sometimes given before surgery to shrink the disease.
Maintenance therapy — PARP-inhibitor tablets and/or bevacizumab after a good response.
Newer options — antibody-drug conjugates and trials for recurrent disease.
Where CELLAAX fits in
We do not replace your oncologist. We review your case, share findings with your treating team, and help you weigh supportive options.
Review
A doctor reads your reports, scans and treatment history.
Coordinate
With your consent, we write to your oncologist before anything is added.
Support
A written supportive-care plan that fits around your main treatment.
Built on our 7 principles
Every plan draws on all seven principles at once, tuned to your diagnosis. Your doctor selects and sequences the therapies, and agrees them with your oncologist before anything starts.
Non-toxic therapies
Precision Molecular Approach · Thermal Energy Therapies
Immunomodulation
Bio-Immunotherapy
Full spectrum nutrition
Biological Therapies · Metabolic Therapies · Therapeutic Nutrition
Detoxification
Detoxification Therapies
Oxygenation
Oxygen Therapies
Restore the microbiome
Anti-Microbial Protocols
Noticed a change?
Most ovarian cancer changes are not cancer, but none should be ignored. See a doctor promptly — even if your last mammogram was clear.
- Persistent abdominal bloating, swelling or feeling full quickly
- Pelvic or lower abdominal pain and discomfort
- Changes in bowel habits or frequent urination
- Unexplained fatigue or unexpected weight loss
Take our questionnaire to determine your next step.
Common questions
What causes ovarian cancer?
The exact cause is not always clear, but risk factors include inherited genetic mutations (BRCA1/BRCA2), increasing age, family history, and reproductive history.
How does CA-125 help in monitoring?
CA-125 is a blood protein. High levels can indicate ovarian cancer activity, and monitoring changes over time helps evaluate how well treatments are working.
What integrative therapies complement ovarian cancer treatment?
CELLAAX provides supportive biological IV therapies, therapeutic nutrition, hyperthermia, and immune support to help manage fatigue, protect healthy tissues, and improve overall resilience.
How can I get started with CELLAAX?
You can book a free consultation directly with our clinical team to review your reports and discuss a personalized integrative care plan.

Ready to discuss your ovarian cancer diagnosis?
Book a free consultation. Our doctors will review your reports and explain how integrative care fits into your journey.
